Dutch otolaryngologist Marein van der Torn hoped to develop a prosthesis that would improve the voice of people who had lost their vocal cords. He investigated the possibilities of a new type of voice ...
Immune-related saliva micro-RNA’s to predict clinical response to a combination of cetuximab and low-dose chemotherapy in head and neck cancer (HNSCC) patients (pts) with poor performance status (PS).
- Key vendors in voice prosthesis devices market focus on longevity and cost-effectiveness of voice prosthesis, improving cancer care for laryngectomy key target - Market to reach valuation of US$190 ...
ALBANY, N.Y., March 4, 2021 /PRNewswire/ -- Voice prosthesis devices are gaining clinical acceptance for speech rehabilitation in patients, especially in patients with laryngeal and hypopharyngeal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results